These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cardio-pulmonary involvement in systemic sclerosis: A study at a tertiary care center. Arakkal G; Chintagunta SR; Chandika V; Damarla SV; Manchala S; Kumar BU Indian J Dermatol Venereol Leprol; 2017; 83(6):677-682. PubMed ID: 29035287 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension and systemic sclerosis: the role of high-resolution computed tomography. Zompatori M; Leone MB; Giannotta M; Galiè N; Palazzini M; Reggiani ML; Bono L; Pollini GS Radiol Med; 2013 Dec; 118(8):1360-72. PubMed ID: 23716290 [TBL] [Abstract][Full Text] [Related]
5. Atypical emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia: a case report. Jazia RB; Ayachi J; Ghzel R; Kacem A; Limem IB; Faidi A; Braiek DB; Chatbouri F; Maatallah A Pan Afr Med J; 2022; 42():295. PubMed ID: 36415340 [TBL] [Abstract][Full Text] [Related]
7. Patterns of Interstitial Lung Disease in Egyptian Patients with Systemic Sclerosis: Relation to Disease Parameters. Abdelati AA; Deghady AA; Abdelhady AM; Bastawy RA; Shaaban A Curr Rheumatol Rev; 2023; 19(2):189-196. PubMed ID: 35984025 [TBL] [Abstract][Full Text] [Related]
8. Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma. Chong WH; Saha BK; Beegle S Am J Med Sci; 2023 Feb; 365(2):198-204. PubMed ID: 35276077 [TBL] [Abstract][Full Text] [Related]
9. Bronchoalveolar Lavage in Systemic Sclerosis Patients: A Systematic Review. da Silva SO; da Paz AS; Farias IMVC; Moreira DS; Ribeiro MAF; Alves TSGN; Lemos ACM; Santiago MB Curr Rheumatol Rev; 2021; 17(2):176-183. PubMed ID: 33185168 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary involvement in systemic sclerosis. Shahin AA Treat Respir Med; 2006; 5(6):429-36. PubMed ID: 17154672 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography. Khanna D; Distler O; Cottin V; Brown KK; Chung L; Goldin JG; Matteson EL; Kazerooni EA; Walsh SL; McNitt-Gray M; Maher TM J Scleroderma Relat Disord; 2022 Oct; 7(3):168-178. PubMed ID: 36211204 [TBL] [Abstract][Full Text] [Related]
12. Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis. de Souza RB; Borges CT; Capelozzi VL; Parra ER; Jatene FB; Kavakama J; Kairalla RA; Bonfá E Respiration; 2009; 77(4):389-97. PubMed ID: 18799868 [TBL] [Abstract][Full Text] [Related]
13. [Factors associated with the development of interstitial lung disease in patients with systemic sclerosis]. Pertuz Rebolledo MM; Arias TG; López Meiller MJ; Dubinsky D Medicina (B Aires); 2022; 82(5):740-745. PubMed ID: 36220031 [TBL] [Abstract][Full Text] [Related]
14. Progressive lung fibrosis and mortality can occur in early systemic sclerosis patients without pulmonary abnormalities at baseline assessment. Vanaken L; Landini N; Lenaerts J; Claeys E; Lenaerts J; Wuyts WA; Verschakelen J; De Langhe E Clin Rheumatol; 2020 Nov; 39(11):3393-3400. PubMed ID: 32385764 [TBL] [Abstract][Full Text] [Related]
15. Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity. Grosicka A; Manasar A; Kucharz EJ; Kotyla PJ Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):541-549. PubMed ID: 31174823 [TBL] [Abstract][Full Text] [Related]